Introna M - Search Results

1

Immunotherapy for HER2-Positive Breast Cancer: Clinical Evidence and Future Perspectives.

Agostinetto E, Montemurro F, Puglisi F, Criscitiello C, Bianchini G, Del Mastro L, Introna M, Tondini C, Santoro A, Zambelli A. Agostinetto E, et al. Among authors: introna m. Cancers (Basel). 2022 Apr 25;14(9):2136. doi: 10.3390/cancers14092136. Cancers (Basel). 2022. PMID: 35565264 Free PMC article. Review.

2

Innovative Clinical Perspectives for CIK Cells in Cancer Patients.

Introna M, Correnti F. Introna M, et al. Int J Mol Sci. 2018 Jan 25;19(2):358. doi: 10.3390/ijms19020358. Int J Mol Sci. 2018. PMID: 29370095 Free PMC article. Review.

3

A novel method using blinatumomab for efficient, clinical-grade expansion of polyclonal T cells for adoptive immunotherapy.

Golay J, D'Amico A, Borleri G, Bonzi M, Valgardsdottir R, Alzani R, Cribioli S, Albanese C, Pesenti E, Finazzi MC, Quaresmini G, Nagorsen D, Introna M, Rambaldi A. Golay J, et al. Among authors: introna m. J Immunol. 2014 Nov 1;193(9):4739-47. doi: 10.4049/jimmunol.1401550. Epub 2014 Sep 29. J Immunol. 2014. PMID: 25267972

4

CIK as therapeutic agents against tumors.

Introna M. Introna M. J Autoimmun. 2017 Dec;85:32-44. doi: 10.1016/j.jaut.2017.06.008. Epub 2017 Jul 2. J Autoimmun. 2017. PMID: 28679475 Review.

5

Mesenchymal stromal cells for prevention and treatment of graft-versus-host disease: successes and hurdles.

Introna M, Rambaldi A. Introna M, et al. Curr Opin Organ Transplant. 2015 Feb;20(1):72-8. doi: 10.1097/MOT.0000000000000158. Curr Opin Organ Transplant. 2015. PMID: 25563994 Review.

6

Cell-based strategies to manage leukemia relapse: efficacy and feasibility of immunotherapy approaches.

Rambaldi A, Biagi E, Bonini C, Biondi A, Introna M. Rambaldi A, et al. Among authors: introna m. Leukemia. 2015 Jan;29(1):1-10. doi: 10.1038/leu.2014.189. Epub 2014 Jun 12. Leukemia. 2015. PMID: 24919807 Review.

7

Long-Term Clinical and Immunological Profile of Kidney Transplant Patients Given Mesenchymal Stromal Cell Immunotherapy.

Perico N, Casiraghi F, Todeschini M, Cortinovis M, Gotti E, Portalupi V, Mister M, Gaspari F, Villa A, Fiori S, Introna M, Longhi E, Remuzzi G. Perico N, et al. Among authors: introna m. Front Immunol. 2018 Jun 14;9:1359. doi: 10.3389/fimmu.2018.01359. eCollection 2018. Front Immunol. 2018. PMID: 29963053 Free PMC article.

8

Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System.

Rotiroti MC, Buracchi C, Arcangeli S, Galimberti S, Valsecchi MG, Perriello VM, Rasko T, Alberti G, Magnani CF, Cappuzzello C, Lundberg F, Pande A, Dastoli G, Introna M, Serafini M, Biagi E, Izsvák Z, Biondi A, Tettamanti S. Rotiroti MC, et al. Among authors: introna m. Mol Ther. 2020 Sep 2;28(9):1974-1986. doi: 10.1016/j.ymthe.2020.05.021. Epub 2020 May 30. Mol Ther. 2020. PMID: 32526203 Free PMC article.

9

Tolerance to Bone Marrow Transplantation: Do Mesenchymal Stromal Cells Still Have a Future for Acute or Chronic GvHD?

Introna M, Golay J. Introna M, et al. Front Immunol. 2020 Dec 11;11:609063. doi: 10.3389/fimmu.2020.609063. eCollection 2020. Front Immunol. 2020. PMID: 33362797 Free PMC article. Review.

10

Independent regulation of c-myc, B-myb, and c-myb gene expression by inducers and inhibitors of proliferation in human B lymphocytes.

Golay J, Cusmano G, Introna M. Golay J, et al. Among authors: introna m. J Immunol. 1992 Jul 1;149(1):300-8. J Immunol. 1992. PMID: 1376749

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

233 results

Search Page